GlassScriptPhysician profile
Nadine Floyd
NPI 1821184052
$1,188.53
in general payments reported to CMS, 2019-2025
25 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $72.06 · 2021: $101 · 2022: $100 · 2023: $103 · 2024: $200 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $131.19 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $111.00 | 2019-2024 | Enseal |
| Axonics, INC. | $96.61 | 2020-2024 | Axonics |
| Merck Sharp & Dohme LLC | $95.56 | 2021-2024 | Zerbaxa, Dificid, Recarbrio |
| Abbvie INC. | $85.14 | 2025 | |
| Tela Bio, INC. | $64.29 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $62.38 | 2022-2025 | Collagenase Santyl |
| Medtronic USA, INC. | $60.59 | 2019 | |
| Aroa Biosurgery Incorporated | $52.59 | 2024-2025 | |
| Kerecis Limited | $52.22 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Shire North American Group INC | $46.30 | 2019 | |
| Astellas Pharma US INC | $41.18 | 2022-2024 | Veozah |
| Braintree Laboratories, INC. | $37.06 | 2025 | Suflave, Sutab |
| Exact Sciences Corporation | $30.36 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $29.06 | 2023 | Coolseal Generator |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $28.34 | 2019 | |
| Azurity Pharmaceuticals, INC. | $27.68 | 2025 | Suflave |
| Takeda Pharmaceuticals U.S.A., INC. | $24.93 | 2022 | |
| Medtronic, INC. | $20.95 | 2024 | Interstim |
| Polynovo North America LLC | $18.40 | 2023 | |
| Thd America, INC. | $17.20 | 2023 | |
| Solventum Corporation | $16.79 | 2024 | Activ.A.C., Prevena |
| Reprise Biomedical, INC. | $16.68 | 2025 | Miro3d |
| Davol INC. | $13.98 | 2025 | Arista |
| Mayne Pharma Commercial LLC | $8.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadine Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.